Patient perceptions of epinephrine auto-injectors: exploring barriers to use.

Scand J Caring Sci

Department of Information Systems and Computing, Brunel University, London, UK.

Published: June 2013

Background: In recent years, government initiatives have proposed that patient self-care should serve as a key resource in response to the anticipated increase in global demand for health care. However, if patients are to be empowered as self-carers, barriers to engagement must be identified and overcome. Anaphylaxis is an increasingly common life-threatening allergic reaction. Patients at risk of anaphylaxis are prescribed epinephrine auto-injectors and play a crucial role in delivering their own care and management of this condition. One key recommendation is that patients routinely carry an epinephrine auto-injector with them and deploy the device when needed. However, only a small proportion of patients that require epinephrine actually receive it.

Objective: To explore the reasons why patients who have been prescribed epinephrine auto-injectors fail to adhere to self-care and management recommendations.

Methods: In-depth interviews with 15 adults who have been prescribed epinephrine auto-injectors were carried out to explore the barriers that exist in the provision of effective self-care and management of anaphylaxis.

Results: Inconsistent health professional advice, perceived stigma of carrying a 'weapon-like' device, poor device design and limited patient training were identified as barriers to carriage or use. Patients were reluctant to carry devices in public because of perceived and observed stigma and suspicion. They were happy to ignore expiry dates, and some participants were confident that the emergency services would provide them with the appropriate care they needed, and therefore, did not carry the device in urban areas.

Conclusions And Clinical Implications: Improved training of patients, the public and health professionals around both the carriage and use of auto-injectors are areas for urgent attention if improved levels of self-care are to be attained. The design of epinephrine auto-injectors should also receive attention as patients often fail to carry them owing to size and aesthetics.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-6712.2012.01045.xDOI Listing

Publication Analysis

Top Keywords

epinephrine auto-injectors
20
prescribed epinephrine
12
patients
8
self-care management
8
epinephrine
7
auto-injectors
6
patient perceptions
4
perceptions epinephrine
4
auto-injectors exploring
4
barriers
4

Similar Publications

Alternatives to Injectable Adrenaline for Treating Anaphylaxis.

Clin Exp Allergy

January 2025

Service de Pneumologie A, APHP, Hôpital Bichat, Paris, France.

Adrenaline is the first line treatment for anaphylaxis and adrenaline auto-injectors (AAI) allow reliable, safe and ergonomic administration in the community. However, AAIs have significant limitations and adrenaline is often not used in anaphylaxis. Innovations to administer adrenaline via alternative routes may potentially improve usage rates and treatment effectiveness.

View Article and Find Full Text PDF

Objective: To investigate awareness and implementation of the Spare Pens (ie, adrenaline auto-injectors (AAIs)) scheme in primary and secondary schools in two regions in Wales.

Design: A cross-sectional pilot study employing a mixed research methods approach was carried out.

Setting And Participants: State primary and secondary schools within Swansea and Pembrokeshire regional authorities were invited to take part.

View Article and Find Full Text PDF
Article Synopsis
  • * Adrenaline is the primary treatment for anaphylaxis, with autoinjectors becoming standard care, but studies indicate that current autoinjectors may not significantly reduce fatal cases.
  • * There are ongoing discussions about finding alternative methods to deliver a sustained adrenaline infusion reliably, as existing autoinjectors produce brief adrenaline spikes that may not be sufficient for effective treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Cow's milk allergy (CMA) overdiagnosis is rising, leading to an increase in prescriptions for low-allergy formulas in England, which grew from 6.1 to 23.3 liters per birth between 2007 and 2023.
  • Prescription rates for these formulas varied widely by region, ranging from 0.8 to 47.6 liters per birth from 2017-2019, with significant correlations identified between low-allergy formula prescriptions and the use of certain medications like milk feed thickeners and anti-reflux medications in children.
  • Regional socio-economic factors and standard CMA guidelines showed no significant association with the rates of low-allergy formula prescribing.
View Article and Find Full Text PDF

To the ER? Can Patients Treat Their Anaphylaxis at Home?

Curr Allergy Asthma Rep

November 2024

Department of Allergy and Immunology, Texas Children's Hospital, Houston, TX, USA.

Purpose Of Review: To discuss if all patients who use self-injectable epinephrine outside the hospital setting require immediate emergency care.

Recent Findings: Prior to 2023, anaphylaxis management guidance universally recommended that patients who use self-injectable epinephrine outside of the hospital or clinic setting immediately activate emergency medical services and seek further care. Additional food-induced anaphylaxis management recommendations specified that all patients always carry 2 auto-injector devices and give a second dose of epinephrine if there was not immediate response within 5 min of injection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!